Active	Status	Sponsor type	Region	Phase	Filter
3 Active 5 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Veldhuizen, Peter J Van
NCT03977467: Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 Inhibitor	Active, not recruiting	2	80	US	Atezolizumab, TECENTRIQ, Chemotherapy (Arm A Only), Tiragolumab	SCRI Development Innovations, LLC, Genentech, Inc.	Non-Small Cell Lung Cancer, Solid Tumor	07/24	07/24
Feeback, Jennifer
No trials found
Altman, Christy
No trials found